Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates

Journal of Antimicrobial Chemotherapy

Volumn 72, Issue 10, 2017, Pages 2787-2791

  Denervaud Tendon, Valérie ^a,b   Poirel, Laurent ^a,b   Connolly, Lynn E ^c   Krause, Kevin M ^c   Nordmann, Patrice ^a,b,d  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b National Reference Center for Emerging Antibiotic Resistance   (Switzerland)

^c Achaogen Inc   (United States)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFTAZIDIME; CEFTRIAXONE; COLISTIN; COTRIMOXAZOLE; DORIPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; PLAZOMICIN; SULFAMETHOXAZOLE; TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; 6'-(HYDROXYLETHYL)-1-(HABA)-SISOMICIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; ESCHERICHIA COLI PROTEIN; MCR-1 PROTEIN, E COLI; SISOMICIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIUM ISOLATE; BROTH DILUTION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENTEROBACTER; ENTEROBACTER ASBURIAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HAFNIA; HAFNIA ALVEI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MCR 1 GENE; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA; MORGANELLA MORGANII; NONHUMAN; PROTEUS; PROTEUS MIRABILIS; PROTEUS VULGARIS; SALMONELLA ENTERICA; SERRATIA; SERRATIA MARCESCENS; AFRICA; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; COLOMBIA; DRUG EFFECT; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; EUROPE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE;

AFRICA; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; COLISTIN; COLOMBIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; EUROPE; HUMANS; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; SISOMICIN;

EID: 85030657187     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkx239     Document Type: Article

References (19)

1. Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 2017; 30: 557-96
2. Ah YM, KimAJ, Lee JY. Colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents 2014; 44: 8-15
3. Poirel L, Jayol A, Bontron S et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 2015; 70: 75-80
4. Jayol A, Nordmann P, BrinkAet al. Heteroresistance to colistin in Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system. Antimicrob Agents Chemother 2015; 59: 2780-4
5. Liu YY, Wang Y, Walsh TR et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016; 16: 161-8
6. Xavier BB, Lammens C, Ruhal R et al. Identification of a novel plasmidmediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill 2016; 21: pii"30280
7. Poirel L, Kieffer N, Liassine N et al. Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli. Lancet Infect Dis 2016; 16: 281
8. Nordmann P, Lienhard R, Kieffer N et al. Plasmid-mediated colistinresistant Escherichia coli in bacteremia in Switzerland. Clin Infect Dis 2016; 62: 1322-3
9. Haenni M, Poirel L, Kieffer N et al. Co-occurrence of extended spectrum b-lactamase and MCR-1 encoding genes on plasmids. Lancet Infect Dis 2016; 16: 281-2
10. Haidar G, Alkroud A, Cheng S et al. Association between the presence of aminoglycoside-modifying enzymes and in vitro activity of gentamicin, tobramycin, amikacin, and plazomicin against Klebsiella pneumoniae carbapenemase-and extended-spectrum-b-lactamase-producing Enterobacter species. Antimicrob Agents Chemother 2016; 60: 5208-14
11. Taber HW, Mueller JP, Miller PF et al. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev 1987; 51: 439-57
12. Jayol A, SalyM,NordmannPet al. Hafnia, an enterobacterial genus naturally resistant to colistin revealed by three susceptibility testing methods. J Antimicrob Chemother 2017; 72: 2507-11
13. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Tenth Edition: Approved Standard M07-10. CLSI,Wayne, PA, USA, 2015
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fourth Informational Supplement M100-S24. CLSI, Wayne, PA, USA, 2014
15. EUCAST. Breakpoints Tables for Interpretation of MICs and Zone Diameters, Version 1.0. 2017. www.eucast.org/mic_distributions_and_ ecoffs
16. Berçot B, Poirel L, Nordmann P. Updated multiplex polymerase chain reaction for detection of 16S rRNAmethylases: high prevalence among NDM-1 producers. DiagnMicrobiol Infect Dis 2011; 71: 442-5
17. Poirel L,Walsh TR, Cuvillier V et al. Multiplex PCR for detection of acquired carbapenemase genes. DiagnMicrobiol Infect Dis 2011; 70: 119-23
18. Doi Y,Wachino JI, Arakawa Y. Aminoglycoside resistance: the emergence of acquired 16S ribosomal RNA methyltransferases. Infect Dis Clin North Am 2016; 30: 523-37
19. Zhou Y, Yu H, Guo Q et al. Distribution of 16S rRNA methylases among different species of Gram-negative bacilli with high-level resistance to aminoglycosides. Eur J Clin Microbiol Infect Dis 2010; 29: 1349-53